Pharmacokinetics/Pharmacodynamics
drugs, altered hepatic blood flow affects both the Css and the Cssu, whereas changes in fu affect only the
Cssu.
↓ Css
↓ Cssu
↑ Q
↓ Q
↑ CLint
↓ CLint
↑ fu
↓ fu
↑ Css
↑ Cssu
↔ Css
↔ Cssu
↔ Css
↔ Cssu
↔ Css
↑ Cssu
↔ Css
↓ Cssu
CLH = Q
Css = Dose
Q
Cssu = fu × Dose
Q
ratio drug.
perfusion during the hyperdynamic phase of sepsis. Critically ill patients in the hyperdynamic phase
of sepsis or septic shock have an increased cardiac output and increased hepatosplanchnic blood flow.
However, no correlation directly relating cardiac output (or an increase in cardiac output) with an
increase in splanchnic blood flow could be established in some studies. Therefore, quantification of
the increase in blood flow and the resultant increase in hepatic metabolism cannot be established. The
clinician is left to assume the potential for increased metabolism of high extraction ratio drugs and the
expected decrease in unbound steady-state concentration and possibly a reduced clinical efficacy.
Any condition or therapy that increases cardiac output could theoretically improve hepatic blood
flow. Although data in humans are lacking, an animal model of endotoxemia showed improved
hepatic blood flow after dobutamine.
Effect of decreased hepatic blood flow
Conditions with a low cardiac output such as hypovolemic or hemorrhagic shock, decompensated
sepsis, myocardial infarction with or without cardiogenic shock, and acute heart failure exacerbation
would be expected to cause a decrease in hepatic blood flow. Human studies to verify this assertion
are lacking. Animal models of decompensated sepsis and cardiogenic shock show reduced hepatic
blood flow, which would be expected to increase the Cssu and potentially increase the effect of, or
produce toxicity for, drugs with high extraction ratios.
Mechanical ventilation has been noted to increase or decrease cardiac output and subsequently hepatic
blood flow, depending on the patient’s condition. Mechanical ventilation may also decrease cardiac
output and subsequently hepatic blood flow because of increased intrathoracic pressure. This pressure
causes a decrease in venous return to the heart, compresses the ventricles, and reduces ventricular
filling. The result is a decrease in cardiac output (N Engl J Med 1981;304:387-92) and hepatic blood